Cardiovascular Health Supplements Market (By Type: Natural Supplements, Synthetic Supplements; By Form: Liquid, Tablet; By Ingredient; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global cardiovascular health supplements market size was estimated at around USD 11.76 billion in 2023 and it is projected to hit around USD 28.05 billion by 2033, growing at a CAGR of 9.08% from 2024 to 2033. 

Cardiovascular Health Supplements Market Size 2024 to 2033

Key Pointers

  • Asia Pacific led the market with a revenue share of 40% in 2023.
  • Europe is predicted to grow at a significant CAGR of 8.92% from 2024 to 2033.
  • By Type, the natural supplements segment contributed more than 71% of market share in 2023 and it is anticipated to grow at the fastest CAGR of 9.49% between 2024 to 2033.
  • By Type, the synthetic supplements segment is expected to expand at the fastest CAGR of 8.18% from 2024 to 2033.
  • By Ingredient, the omega fatty acids segment captured the largest market share of 28% in 2023.
  • By Ingredient, the herbs & botanicals segment is expected to grow at the fastest CAGR of 10.39% from 2024 to 2033.
  • By Form, the softgels segment registered the maximum market share of 38% in 2023. 
  • By Form, the capsules segment is predicted to grow at the remarkable CAGR of 9.97% from 2024 to 2033.
  • By Distribution Channel, the offline segment registered the largest market share of 72% in 2023. 
  • By Distribution Channel, the online segment is expected to expand at the highest CAGR of 10.49% from 2024 to 2033.

Cardiovascular Health Supplements Market Overview 

The cardiovascular health supplements market is witnessing a significant surge in demand owing to the growing awareness about heart health and the increasing prevalence of cardiovascular diseases globally. Cardiovascular health supplements, comprising a wide range of vitamins, minerals, antioxidants, and herbal extracts, are designed to support heart function and reduce the risk of heart-related ailments.

Cardiovascular Health Supplements Market Growth 

The growth of the cardiovascular health supplements market can be attributed to several key factors. Firstly, the increasing awareness among individuals about the importance of cardiovascular health and the rising prevalence of heart-related diseases are driving the demand for these supplements. Secondly, the aging population, which is more susceptible to heart issues, is creating a significant consumer base for cardiovascular health products. Additionally, unhealthy lifestyles, sedentary habits, and stressful work environments have contributed to a surge in heart problems, prompting people to seek preventive measures through supplements. Furthermore, advancements in research and development, leading to innovative formulations and natural ingredients, are enhancing the efficacy of these supplements, attracting health-conscious consumers.

Report Scope of the Cardiovascular Health Supplements Market

Report Coverage Details
Market Revenue by 2033 USD 28.05 billion
Growth Rate from 2024 to 2033 CAGR of 9.08%
Revenue Share of Asia Pacific in 2024 39%
CAGR of Europe from 2024 to 2033 8.91%
Base Year 2023
Forecast Period 2024 to 2033
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)Companies Covered

 

Cardiovascular Health Supplements Market Dynamics

Drivers

  • Unhealthy Lifestyles: Sedentary habits, poor dietary choices, and high-stress levels in modern lifestyles have escalated the incidence of cardiovascular diseases, creating a demand for supplements addressing these concerns.
  • Innovative Formulations: Ongoing research and development efforts lead to innovative supplement formulations, incorporating natural and organic ingredients, enhancing the efficacy and attracting health-conscious consumers.

Restraints

  • Consumer Skepticism: Despite the market growth, some consumers remain skeptical about the effectiveness of supplements. Addressing misinformation and building trust through transparent marketing and educational initiatives are essential to overcoming this skepticism.
  • Intense Competition: The market is highly competitive, with numerous companies offering a wide array of cardiovascular health supplements. Establishing a unique market presence and differentiating products from competitors become challenging amidst such competition, requiring innovative strategies to stand out.

Opportunities

  • Targeting Aging Population:  With the global population aging, there is a growing market for supplements catering to the specific needs of older adults. Formulating products addressing age-related heart health concerns can be a lucrative opportunity for companies in this sector.
  • Focus on Holistic Health:  Consumers are increasingly adopting a holistic approach to health, emphasizing not only cardiovascular health but also overall well-being. Cardiovascular health supplements companies can diversify their product offerings to include supplements supporting mental health, immune system, and general wellness, catering to the holistic health trend.

Type Insights

The natural supplements segment held the largest market share of 71% in 2023 and it is expected to grow at the fastest CAGR of 9.49% over the forecast period. Natural supplements are derived from organic sources, such as herbs, plants, and marine extracts, known for their inherent health benefits. These supplements often contain vitamins, minerals, antioxidants, and omega-3 fatty acids sourced from natural sources. Due to their organic origins, natural supplements are perceived by consumers as healthier and safer alternatives. They are favored by individuals seeking products with minimal processing and additives, aligning with the growing trend towards natural and holistic health solutions.

The synthetic supplements segment is anticipated to grow at a significant CAGR of 8.18% during forecast period. Synthetic supplements are chemically formulated in laboratories to mimic the properties of natural nutrients. These supplements are designed to provide specific vitamins, minerals, and other essential compounds essential for cardiovascular health. Synthetic supplements offer precise control over nutrient concentrations, ensuring standardized dosages. They are often recommended in clinical settings where targeted nutrient supplementation is required.

Ingredient Insights

The omega fatty acids segment registered the maximum market share of 28% in 2023. Omega fatty acids, particularly omega-3, are essential polyunsaturated fats known for their profound cardiovascular benefits. Derived mainly from fish oil and certain plant sources, omega-3 fatty acids have gained immense popularity due to their ability to reduce inflammation, lower blood pressure, and enhance overall heart health. Research studies supporting their efficacy have bolstered their reputation, making them a cornerstone ingredient in cardiovascular health supplements.

  • For instance, according to a study published by the Journal of the American Heart Association in June 2022, consuming 3 grams daily of omega-3 fatty acids via supplements or food has decreased blood pressure.

The herbs & botanicals segment is expected to grow at the fastest CAGR of 10.39% from 2024 to 2033. Herbs and botanicals have been integral to traditional medicine systems for centuries, owing to their medicinal properties. In the context of cardiovascular health supplements, various herbs and botanicals have gained prominence for their heart-friendly attributes. For instance, garlic is renowned for its potential to lower blood pressure and cholesterol levels, while hawthorn extract is valued for its ability to improve blood circulation and strengthen the heart muscle.

Form Insights

The softgels segment held the largest market share of 38% in 2023. Softgels, characterized by their gelatinous outer coating, encase liquid or oil-based supplements. This form offers several advantages, such as improved absorption rates and enhanced bioavailability of the enclosed nutrients. Softgels are particularly favored for cardiovascular health supplements containing omega-3 fatty acids, as the encapsulation method protects these sensitive oils from oxidation, ensuring the potency of the supplement. The smooth texture and easy swallowing make softgels a convenient option, especially for individuals with difficulty in ingesting larger pills or tablets.

The capsules segment is projected to exhibit the fastest CAGR of 9.97% over the forecast period. Capsules, on the other hand, consist of a two-piece outer shell, usually made from gelatin or plant-based materials, enclosing powdered or granulated supplement ingredients. This form is versatile and allows for the encapsulation of various nutrients, including vitamins, minerals, and herbal extracts, relevant to cardiovascular health. Capsules are preferred for their flexibility in formulation, enabling manufacturers to create customized blends tailored to specific heart health needs.

Distribution Channel Insights

The offline segment contributed the largest market share of 72% in 2023. Offline distribution channels, which include brick-and-mortar stores, pharmacies, supermarkets, and specialty health stores, have long been the traditional way consumers purchase supplements. These physical retail outlets offer consumers the advantage of a tangible shopping experience, allowing them to see, touch, and evaluate products before making a purchase decision. Knowledgeable staff in these stores can also provide personalized recommendations and guidance, enhancing the consumer's shopping experience.

  • For instance, in May 2023, Nordic Naturals partnered with Walmart to offer its omega-3 supplement in across 2,500 Walmart stores.

Cardiovascular Health Supplements Market Share, By Distribution Channel, 2023 (%)

The online segment is expected to expand at the highest CAGR of 10.49% over forecast period. The online distribution channel has witnessed exponential growth with the advent of e-commerce platforms. Online retailing offers consumers unparalleled convenience and accessibility, allowing them to browse a vast array of cardiovascular health supplements from the comfort of their homes. The online marketplace provides detailed product information, customer reviews, and often offers a wider selection than physical stores. This channel appeals to the tech-savvy, time-conscious consumers seeking the ease of ordering products with just a few clicks. Additionally, online platforms enable suppliers and manufacturers to reach a global audience, breaking down geographical barriers and expanding market reach.

  • For instance, in November 2020, Amway shifted from offline to online, with online sales doubling to more than 70%.

Regional Insights

Asia Pacific dominated the market with a revenue share of 40% in 2023. Asia-Pacific, with countries like China, Japan, and India, represents a burgeoning market for cardiovascular health supplements. Rapid urbanization, changing lifestyles, and rising disposable incomes have elevated awareness about heart health in this region. The market in Asia-Pacific is characterized by a significant interest in herbal supplements, reflecting the rich traditional herbal medicine heritage of several countries.

Cardiovascular Health Supplements Market Share, By Region, 2023 (%)

In Europe, countries such as Germany, France, and the United Kingdom have witnessed a surge in demand for cardiovascular health supplements, driven by an aging population and an increasing focus on holistic well-being. European consumers often prioritize supplements made from herbal and botanical ingredients, reflecting a preference for traditional remedies.

 

Cardiovascular Health Supplements Market Key Companies

  • NOW Health Group, Inc.
  • Bright Lifecare Pvt Ltd (Truebasics.com)
  • Natural Organics, Inc.
  • DaVinci Laboratories of Vermont
  • Nordic Naturals
  • Thorne HealthTech, Inc.
  • Nestle (Pure Encapsulations, LLC.)
  • Amway
  • InVite Health
  • GNC Holdings, LLC

Cardiovascular Health Supplements Market Report Segmentations:

By Type

  • Natural Supplements
  • Synthetic Supplements

By Ingredient

  • Vitamins & Minerals
  • Herbs & Botanicals
  • Omega Fatty Acids
  • Coenzyme Q10 (CoQ10)
  • Others

By Form

  • Liquid
  • Tablet
  • Capsules
  • Softgels
  • Powder
  • Others

By Distribution Channel

  • Offline
  • Online

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global cardiovascular health supplements market size was reached at USD 11.76 billion in 2023 and it is projected to hit around USD 28.05 billion by 2033.

The global cardiovascular health supplements market is growing at a compound annual growth rate (CAGR) of 9.08% from 2024 to 2033.

The Asia Pacific region has accounted for the largest cardiovascular health supplements market share in 2023.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cardiovascular Health Supplements Market 

5.1. COVID-19 Landscape: Cardiovascular Health Supplements Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cardiovascular Health Supplements Market, By Type

8.1. Cardiovascular Health Supplements Market, by Type, 2024-2033

8.1.1. Natural Supplements

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Synthetic Supplements

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Cardiovascular Health Supplements Market, By Ingredient

9.1. Cardiovascular Health Supplements Market, by Ingredient, 2024-2033

9.1.1. Vitamins & Minerals

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Herbs & Botanicals

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Omega Fatty Acids

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Coenzyme Q10 (CoQ10)

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Cardiovascular Health Supplements Market, By Form 

10.1. Cardiovascular Health Supplements Market, by Form, 2024-2033

10.1.1. Liquid

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Tablet

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Capsules

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Softgels

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Powder

10.1.5.1. Market Revenue and Forecast (2021-2033)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Cardiovascular Health Supplements Market, By Distribution Channel 

11.1. Cardiovascular Health Supplements Market, by Distribution Channel, 2024-2033

11.1.1. Offline

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Online

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Cardiovascular Health Supplements Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.1.3. Market Revenue and Forecast, by Form (2021-2033)

12.1.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Form (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Form (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.2.3. Market Revenue and Forecast, by Form (2021-2033)

12.2.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Form (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Form (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Form (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Form (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.3.3. Market Revenue and Forecast, by Form (2021-2033)

12.3.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Form (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Form (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Form (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Form (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.4.3. Market Revenue and Forecast, by Form (2021-2033)

12.4.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Form (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Form (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Form (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Form (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.5.3. Market Revenue and Forecast, by Form (2021-2033)

12.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Form (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Ingredient (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Form (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

Chapter 13. Company Profiles

13.1. NOW Health Group, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bright, Lifecare Pvt Ltd (Truebasics.com)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Natural Organics, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. DaVinci Laboratories of Vermont

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Nordic Naturals

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Thorne HealthTech, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Nestle (Pure Encapsulations, LLC)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Amway

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. InVite Health

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. GNC Holdings, LLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers